ArticleVaccines2023

Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.

Susana Sainz de la Maza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.